EUVIMEDEUVIMED entdecken
Crossref

Real-world outcomes of 600 drug-coated balloon angioplasties

Marco Franchin, Maria Cristina Cervarolo, Angela Veneziano iD, Sophie Salvadore, Silvia Velo, Gabriele Piffaretti, Matteo Tozzi

The Journal of Vascular Access · 2026

DOI: 10.1177/11297298251362927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Marco Franchin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery, University of Insubria, Asst-settelaghi Universitary Teaching Hospital, Varese, Italy. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Graft Occlusion, Vascular, Arteriovenous Shunt, Surgical, Coated Materials, Biocompatible. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The principal challenge in maintaining functional vascular access for hemodialysis is managing outflow stenoses, which are primarily caused by intimal hyperplasia. These stenoses are the leading cause of access dysfunction, leading to inadequate dialysis, increased morbidity, and frequent reinterventions. While drug-coated balloons (DCBs) have emerged as a promising solution by delivering antiproliferative agents to reduce restenosis rates, further clinical insights are needed to establish their role in vascular access management. Materials and methods: We conducted a single-center, retrospective cohort study analyzing 600 DCB angioplasties performed on 234 patients with stenoses or thromboses in arteriovenous fistulas (AVFs) or vascular access grafts (AVGs). Central vein stenoses accounted for 17.5% of cases. Inclusion criteria comprised symptomatic or asymptomatic stenoses >50% detected through Doppler ultrasound. DCBs (Aperto OTW, Cardionovum GmbH, Bonn, Germany) were used following pre-dilatation. Patients were followed for a minimum of 6 months, with functional patency and complications as the primary outcomes.

Results

The technical success rate was 95%, with functional patency rates of 82%, 63%, and 42%, at 12, 24, and 36 months, respectively. Freedom from restenosis was 71% in AVFs, 64% in AVGs, and 57% in central vein stenoses at 12 months. The annual reintervention rate was 1.3 (IQR: 0.9–3.1). No major adverse events were reported, and vascular injuries occurred in 1.3% of cases. Univariate analysis revealed no significant impact of comorbidities on outcomes. Our clinical approach prioritizes DCB angioplasty as the first-line treatment, reserving stent grafts for select cases with recurrent or complex stenoses to preserve vascular anatomy and surgical options.

Conclusion

Drug-coated balloon angioplasty is a safe and effective treatment for vascular access stenoses, demonstrating robust functional patency and low restenosis rates. Our findings support the use of paclitaxel-eluting DCBs as a cornerstone in vascular access management, emphasizing their role in reducing complications and maintaining long-term access functionality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, BalloonGraft Occlusion, VascularArteriovenous Shunt, SurgicalCoated Materials, BiocompatibleRenal DialysisBlood Vessel Prosthesis ImplantationCardiovascular AgentsVascular Access DevicesThrombosisHumansRetrospective StudiesVascular PatencyFemaleMaleAgedTreatment OutcomeMiddle AgedTime FactorsRisk FactorsConstriction, PathologicRecurrenceAged, 80 and over

Stichwörter der Autor:innen

AV fistuladialysisdialysis accessprosthetic graftstechniques and proceduresultrasonography - Doppler evaluation

Substanzen

Coated Materials, BiocompatibleCardiovascular Agents

Autor:innen und Institutionen

  • Vascular Surgery, University of Insubria, Asst-settelaghi Universitary Teaching Hospital, Varese, Italy.

ORCID-Profile: Angela Veneziano

Zitieren

APA

Franchin, M., Cervarolo, M. C., Veneziano, A., Salvadore, S., Velo, S., Piffaretti, G., & Tozzi, M. (2026). Real-world outcomes of 600 drug-coated balloon angioplasties. The Journal of Vascular Access. https://doi.org/10.1177/11297298251362927

Vancouver

Franchin M, Cervarolo MC, Veneziano A, Salvadore S, Velo S, Piffaretti G, et al. Real-world outcomes of 600 drug-coated balloon angioplasties. The Journal of Vascular Access. 2026. doi:10.1177/11297298251362927

BibTeX
@article{Franchin2026,
  author = {Franchin, Marco and Cervarolo, Maria Cristina and Veneziano, Angela and Salvadore, Sophie and Velo, Silvia and Piffaretti, Gabriele and Tozzi, Matteo},
  title = {Real-world outcomes of 600 drug-coated balloon angioplasties},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298251362927}
}
Kostenlos starten →